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We analysed the effect of (2)-epicatechin and cocoa extract on the activation of a lymphoid cell line. Particularly the expression of IL-2 receptor a (IL-2Ra
or CD25) and, the secretion of IL-2 and IL-4 were established after flavonoid treatment. Two media culture conditions (1 and 10 % of fetal calf serum
supplementation) and the different moments of flavonoid addition (simultaneously or 2 h before cell-activation) were compared. IL-2Ra (CD25) expression
on activated cells was significantly reduced by epicatechin and cocoa extract in a dose-dependent manner, achieving the highest inhibition of about 50 %
when flavonoids were added 2 h before stimulation. IL-2 secretion was also inhibited by the presence of both epicatechin and cocoa extract, displaying 60
and 75 % of inhibition, respectively. Cocoa flavonoids were also able to enhance 3–4·5-fold IL-4 release. In summary, cocoa extract down-modulated
T lymphocyte activation and therefore the acquired immune response. This fact could be important in some states of the immune system hyperactivity
such as autoimmune or chronic inflammatory diseases.
Cocoa: Epicatechin: Lymphocyte: IL-2
At present, the apparent relationship between diet components
and immune functions is clear (Kelly & Bendich, 1996; Kubena
& McMurray, 1996; Field, 2000). Scientists have understood
since the 1960s that the immune system plays a critical role in
the relationship between malnutrition and infection. However, a
major focus of current research is the possibility of modulating
the immune system of healthy people by nutrition with the goal
of improving health. For example, some scientists have shown
that supplementation with certain nutrients, especially those
with antioxidant activities, may improve immune function
(Kelly & Bendich, 1996; Meydani et al. 1998).
Cocoa (Theobroma cacao) was considered a divine food by the
Maya and Aztec civilisations; Mayans were consuming products
derived from cocoa from as early as 600 BC (Hurst et al. 2002).
Several documents, among them the Badianus Manuscript, the
Florentine Codex and the Princeton Codex, show the use of
cocoa for medicinal purposes. Over 100 different therapeutic
uses are described: chocolate was eaten to treat heart pain, intes-
tinal complaints and infections, and to reduce fatigue and increase
sexual appetite (Dillinger et al. 2000).
Cocoa seeds are a rich source of flavonoids, mainly, (2 )-epica-
techin, (þ )-catechin and polymers derived from these monomers
called procyanidins (Hammerstone et al. 1999). The cocoa flavo-
noid content is difficult to establish because it depends on many
factors (geography, climate, storage conditions, manufacturing
processes, food matrix etc.; Manach et al. 2004). Cocoa powder
is described as capable of reaching up to 70 mg/g
polyphenols (expressed as catechin), whereas chocolate contains
between 5 and 8·4 mg/g depending on the type (Vinson et al.
1999; Waterhouse et al. 1996). Quercetin, isoquercitin (quercetin-
3-O-glucoside) and quercetin-3-O-arabinose are also present in
cocoa powder in lower quantities although it is believed that
these compounds might be important contributors to the health
benefits of cocoa (Lamuela et al. 2001). Recently, other flavo-
noids have been identified in cocoa powder, such as hyperoside
(quercetin-3-O-galactoside), naringenin, luteolin, apigenin and
some O-glucosides and C-glucosides of these compounds
(Sa´nchez-Rabaneda et al. 2003).
Little is known about the bioavailability of procyanidins.
A recent human feeding study has proved that cocoa procyanidins
are stable during gastric transit (Rios et al. 2002). Epicatechin and
catechin are rapidly absorbed and found in human plasma
(Richelle et al. 1999; Baba et al. 2000; Bell et al. 2000). In
addition, Holt et al. (2002) have detected procyanidin dimer B2
(epicatechin-(4b-8)-epicatechin) in human plasma 30 min after
cocoa beverage consumption.
There are some studies that show the contribution of cocoa and
chocolate to the total flavonoid intake. Arts et al. (1999), in a
Dutch nutritional survey, found that cocoa products contribute
20 % of the dietary catechins intake in this population. Moreover,
according to the food consumption data of the Spanish Depart-
ment of Agriculture, Fishery and Food (2002), cocoa products
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can be an important source of dietary flavonoids in children and
teenagers because cocoa powder consumption is relatively high,
about 6–8 kg per child per year, equating to a consumption of
about 20 g/d cocoa powder containing 5 g cocoa, 14 g sugar and
0·5 g fat. The effects that this cocoa consumption may represent
have not yet been well established.
Cocoa flavonoids are antioxidants (Pietta, 2000). These flavo-
noids could be beneficial in some situations such as major chronic
diseases with high presence of reactive oxidant species such as
CHD (Weisburger, 2001; Steinberg et al. 2003; Kris-Etherton &
Keen, 2002). It has also been reported that flavonol-rich cocoa
inhibits epinephrine-stimulated platelet activation and function,
qualitatively similar to aspirin (Pearson et al. 2002). The effects
of cocoa flavonoids on the immune system are less known and
are centred on the inflammatory response of macrophages and
monocytes. Thus, cocoa polyphenols inhibit anion superoxide
and hydrogen peroxide on activated granulocytes (Sanbongi
et al. 1997). Moreover, cocoa procyanidins are able to decrease
plasma leukotriene concentrations (Schramm et al. 2001). In
addition, isolated procyanidin fractions have different effects on
the secretion of certain cytokines (IL-1b, TNF-a, TGF-b1, IL-2,
IL-5 and IL-4) from peripheral mononuclear cells, depending
on oligomer length (Mao et al. 2000a,b,c, 2002a,b, 2003).
These suggestions prompted us to extend the research focused
on the study of total polyphenols contained in cocoa powder on
lymphocyte T activation. In the present work, we analyse the
effect of (2 )-epicatechin and cocoa extract on the expression of
IL-2 receptor a (IL-2Ra or CD25) as well as on the secretion
of IL-2 and IL-4 from stimulated murine EL4.BU.OU6 cell
line. IL-2 and IL-2Ra are markers of early lymphocyte T acti-
vation that are involved in both humoral and cellular specific
immune response. IL-2 is the first cytokine secreted by activated
T lymphocytes. It binds to IL-2R which is overexpressed after
activation and leads to the stimulation of a set of complex
signal transduction pathways that produces cell proliferation
(Nelson & Willerford, 1998). IL-4 is secreted later by activated
T lymphocytes (Th2) and helps B cells to proliferate and differen-
tiate in antibody secreting cells (Constant & Bottomly, 1997).
Materials and methods
Reagents
(2 )-Epicatechin, phorbol 12-myristate 13-acetate (PMA), 30 %
hydrogen peroxide, propidium iodide, 2-mercapto-ethanol and
o-phenylenediamine dihydrochloride were obtained from Sigma-
Aldrich (Madrid, Spain). Dulbecco’s Modified Eagle Medium
High Glucose, fetal calf serum (FCS), glutamine and mixture of
penicillin–streptomycin–amfoterycin B were purchased from
PAA (Pasching, Austria). Arginine was provided by Invitrogen
(Prat del Llobregat, Spain). IL-1a, fluorescein isothiocyanate
(FITC)-conjugated rat anti-mouse CD25 (IL-2Ra chain, p55)
monoclonal antibody (mAb), rat anti-mouse CD16/CD32 (Fcg III/
II receptor) mAb, mouse IL-2 ELISA set and mouse IL-4 ELISA
set were obtained from BD Biosciences (Heidelberg, Germany).
Sodium azide was provided by Merck (Darmstadt, Germany).
Cocoa extract preparation
Natural Forastero cocoa powder from Malaysia provided by
Nutrexpa (Barcelona, Spain) was used. Cocoa was subjected to
an extraction of phenols following the Andre´s-Lacueva et al.
(2000) method with some modifications. Briefly, 10 g cocoa
were mixed with 8 ml deionised water at boiling point and
vortexed for 1 min. Then, 32 ml ethanol were added and the sol-
ution was shaken and vortexed for 3 min. The solution was centri-
fuged for 15 min at 1800 g at 48C. The supernatant was
concentrated under vacuum to a final volume of 4 ml, avoiding
light exposure. To clean the extract, the sample was applied to
a Water Oasis HLB extraction cartridge and washed with water
and 5 % ethanol in water. The phenols were eluted with ethanol
and the extract was evaporated under a stream of nitrogen, avoid-
ing dryness, and reconstituted to 4 ml with ethanol–water (80 %,
v/v). The total phenolic content was determined in the extract
according to the Folin–Ciocalteu method (Swain & Hillis,
1969). The cocoa extract obtained and used in this study con-
tained 20·4 mg/ml total polyphenols expressed as catechin. This
extract was pooled and stored at 2808C until used. Stock sol-
utions of (2)-epicatechin were prepared in a minimum volume
of ethanol and then were pooled and stored at 2808C. Just
before the treatment of the EL4.BU.OU6 cell line, cocoa polyphe-
nolic extract and (2 )-epicatechin ethanolic solutions were appro-
priately diluted in fresh culture medium in order to obtain the
desired concentrations in cell suspensions. Total polyphenol con-
centrations in the cocoa extract ranged between 5 and 80mg/ml.
Epicatechin was used at final concentrations of 200 and
400mM, corresponding to 58 and 116mg/ml of this polyphenol.
As cocoa extract and epicatechin were applied to non-physiologi-
cal conditions in transformed cells, concentrations used were
higher than physiological ones.
Treatment of EL4.BU.OU6 cell line with epicatechin and cocoa
polyphenolic extract
The thymoma murine EL4.BU.OU6 cell line was provided by
ECACC (European Collection of Animal Cell Cultures, Wiltshire,
UK). It was maintained in Dulbecco’s Modified Eagle Medium
High Glucose supplemented with 10 % FCS, 2 mM-glutamine,
0·05 mM-2-mercapto-ethanol, 1·16 g/ml L-arginine, 100 IU/ml
penicillin, 100mg/ml streptomycin and 250mg/ml amfoterycin
B. Cells were grown in culture flasks at 378C and 5 % CO2 atmos-
phere in humidified air.
To study the influence of cocoa extract on EL4.BU.OU6 cell
line, cells were resuspended at 1 £ 106 per ml in medium contain-
ing 1 or 10 % FCS and incubated in a twelve-well plate. Two
hours later, cells were activated by the addition of 10 ng/ml
PMA and 0·2 ng/ml IL-1a or remained unstimulated. Immedi-
ately, resting and stimulated cells were incubated in the presence
of (2)-epicatechin at 200mM (58mg/ml) and 400mM (116mg/ml)
or cocoa extract at 5, 10, 20, 40 and 80mg/ml. Addition of flavo-
noids was performed in low light. Controls were incubated with
flavonoid vehicle (ethanol). In some experiments, flavonoids
were added 2 h before PMA stimulation. After a 24 h activation
period, cells were harvested and centrifuged (500 g, 5 min, 48C).
Pellets were immediately used to study cell viability and CD25
expression. Supernatants were stored at 2808C until IL-2 and
IL-4 quantification by ELISA.
Cell viability and CD25 expression assay by flow cytometry
Cells were incubated with rat anti-mouse CD16/CD32 mAb
(15 min, 48C) in order to avoid non-specific binding. Cells were
E. Ramiro et al.860
then washed twice with phosphate-buffered saline solution contain-
ing 1 % FCS and 0·09 % NaN3 (PBS-FCS-Az). Cells were labelled
with a saturating concentration of FITC-anti-CD25 (30 min, 48C in
darkness). Irrelevant monoclonal antibody of the same isotype as
anti-CD25 (IgG1) was used as negative control for each treatment.
Cells were washed twice and resuspended with PBS-FCS-Az. Pro-
pidium iodide was added to label dead cells. Immediately, cells were
analysed on a Coulter Epics XL2 Corporation Fluorescence-Acti-
vated Cell Sorter (Miami, FL, USA).
Mean fluorescence intensities (MFI) and percentages of PI-
stained cells were assessed by cytometer software (System II
Software v.3·0, Coulter Corp.). Viable cells were selected accord-
ing to the side and forward scatter characteristics of EL4.BU.OU6
cell line and propidium iodide fluorescence. MFI, which are pro-
portional to the amount of CD25 on each cell, were obtained from
the analysis of 6000 viable cells. In order to discard the unspecific
fluorescence due to resting and activation conditions or flavonoid
presence, results from the cytometer were expressed as follows:
Percentage of CD25 expression ¼ F=C £ 100
where C ¼ (MFICD25 2 MFIIgG1)stimulated cells* 2 (MFICD252
MFIIgG1)resting cells* and F ¼ (MFICD25 2 MFIIgG1)stimulated cellsþ
flavonoids* 2 (MFICD25 2 MFIIgG1)resting cellsþflavonoids* (*MFI after
staining with FITC-conjugated anti-CD25 (or IgG1) mAb
obtained from stimulated (or resting) cells.)
IL-2 and IL-4 quantification by ELISA
Levels of IL-2 and IL-4 secreted by EL4.BU.OU6 cells after 24 h of
PMA and IL-1a activation were measured using an ELISA sand-
wich assay. Briefly, an appropriate dilution of anti-mouse IL-2 or
anti-mouse IL-4 mAb was incubated on a ninety-six-microwell
polystyrene plate overnight at 48C. Unbound antibodies were
washed away using PBS with 0·05 % Tween-20 and the plate was
blocked with PBS–10 % FCS (1 h, room temperature). Then, super-
natants and standard cytokine dilutions were added (3 h, room tem-
perature). The plate was washed again and a dilution of biotinylated
anti-mouse IL-2 or anti-mouse IL-4 mAb and avidine-horseradish
peroxidase was added to each well (1 h, room temperature). After
washing, cytokines captured by specific mAb were detected by
addition of the enzyme substrate (H2O2) and a chromogenic solution
(o-phenylenediamine dihydrochloride). The reaction was stopped
after 30 min with 3 M-H2SO4. Absorbance was measured at
492 nm. Results were interpolated into standard curves performed
with recombinant mouse IL-2 or IL-4.
To study the effect of flavonoids on IL-2 secretion, concen-
trations of IL-2 secreted by untreated stimulated cells alone was
considered as 100 %. The results obtained from stimulated cells
in the presence of flavonoids were referred to each parallel
untreated stimulated cell.
Statistical analysis
The software package SPSS 10·0 (SPSS Inc, Chicago, IL, USA)
was used for statistical analysis. A conventional ANOVA was
performed with flavonoid concentration as the independent vari-
able and the levels of cytokines and IL-2 receptor (CD25) as
dependent variables. When flavonoid content had a significant
effect on the dependent variable, a Student’s t test was performed.
Moreover, comparisons between epicatechin and cocoa extract
treatments were made by means of Student’s t test with a signifi-
cance level of P,0·05.
Results
Viability of EL4.BU.OU6 cells after phorbol 12-myristate
13-acetate activation and in flavonoid presence
The effect of cocoa flavonoids on cell viability was determined in
resting and stimulated lymphocytes after a 24 h incubation period
and under two different media conditions (1 and 10 % FCS sup-
plementation). Epicatechin (200, 400mM) and cocoa polyphenolic
extract (5–80mg/ml) were tested. Cell viability was reduced from
90 % to 65 % by PMA and IL-1a stimulation in both 1 and 10 %
FCS media conditions. Epicatechin did not modify cell viability
when it was added in both FCS culture conditions. In 1 % FCS,
cell viability was not affected by any of the cocoa extract concen-
trations tested. In contrast, at 10 % FCS condition, cocoa extract
improved viability about 8 %.
IL-2Ra (CD25) expression of EL4.BU.OU6 cells after phorbol
12-myristate 13-acetate activation and in flavonoid presence
CD25 expression was only assessed in viable cells. EL-4.BU.OU6
cells showed low CD25 expression in the resting state (Fig. 1) but
it increased two to five times after 24 h activation with PMA and
IL-1a in culture conditions of 1 or 10 % FCS (Fig. 1).
Fig. 2 summarises the effect of epicatechin and cocoa extract
on IL-2Ra expression of stimulated EL-4.BU.OU6 cells in culture
conditions of 10 and 1 % FCS. When cells were stimulated and
simultaneously treated with flavonoids in the richest condition
(10 % FCS), CD25 expression was not significantly modified
with the exception of one concentration (20mg/ml cocoa extract;
P,0·01; Fig. 2(A)). On the contrary, under 1 % FCS, CD25
expression was significantly reduced in the presence of 400mM-
epicatechin (P,0·05) and 10–80mg/ml cocoa extract (P,0·01;
Fig. 2(B)). The highest inhibition achieved was about 40 % both
for 400mM-epicatechin (that corresponds to 116mg/ml polyphe-
nols) and cocoa extract at concentrations ranging between 10
and 40mg/ml polyphenols.
To ascertain whether time of flavonoid addition influenced their
inhibitory effect, CD25 expression was subsequently studied after
addition of epicatechin and cocoa extract 2 h before PMA
Fig. 1. Representative histogram of resting (A) and 24h phorbol 12-myristate
13-acetate-activated (B) EL4.BU.OU6 cells after staining with fluorescein iso-
thiocyanate (FITC)-anti-CD25 monoclonal antibody.
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activation in condition of 1 % FCS. Both cocoa extract (10, 40
and 80mg/ml) and epicatechin (200, 400mM) decreased CD25
expression on EL4.BU.OU6 cells in a dose-dependent way
(P,0·01; Fig. 2(C)). Cocoa extract produced a higher effect
than that of epicatechin. Thus, 80mg/ml cocoa extract induced
a significantly higher inhibition (P,0·01) than that produced by
200 and 400mM-epicatechin (that represent 58 and 116mg/ml
polyphenols, respectively). Moreover, cocoa extract achieved an
inhibitory effect of about 50 % that was higher than that obtained
with simultaneous addition (Fig. 2(B)).
IL-2 secretion of EL-4.BU.OU6 cells after phorbol 12-myristate
13-acetate activation and in flavonoid presence
ELISA analysis of supernatants after 24 h incubation showed
undetectable IL-2 levels in resting cells. In these conditions,
neither cocoa extract nor epicatechin addition produced IL-2
secretion. PMA stimulation induced IL-2 secretion, which was
higher in 10 % FCS (1180·06 (SEM 28·4) ng/ml) than in 1 %
FCS-supplemented media (653·96 (SEM 28·7) ng/ml).
Epicatechin (200, 400mM) reduced significantly IL-2 secretion
between 10 % and 25 % (P,0·05) and there was no difference
among inhibition levels at 10 and 1 % FCS culture conditions
(Fig. 3(A) and (B), respectively). Cocoa extract (10–40mg/ml)
also had an inhibitory effect in 1 % FCS media, displaying a
reduction of 8–15 % (P,0·01; Fig. 3(B)). When the study was
carried out with 10 % FCS, 80mg/ml cocoa extract was necessary
to obtain a significant reduction in IL-2 production (20 % inhi-
bition; P,0·01; Fig. 3(A)). However, when epicatechin was
added to cells 2 h before activation, it was able to inhibit IL-2
secretion up to 60 % (P,0·01; Fig. 3(C)). Interestingly, cocoa
extract, in this condition, produced an IL-2 release inhibition
higher than that produced by epicatechin (P,0·01) and was
able to limit IL-2 production to 25 % (Fig. 3(C)).
IL-4 secretion of EL4.BU.OU6 cells after phorbol 12-myristate
13-acetate activation and in flavonoid presence
Supernatants of EL4.BU.OU6 cells were used to quantify IL-4
secretion. Resting cells secreted undetectable amounts of this
cytokine. PMA activation during 24 h induced low levels of IL-
4 that was about 4·5 (SEM 2·5) pg/ml in conditions of 1 % FCS
culture medium and 5·3 (SEM 2·2) pg/ml in 10 % FCS-sup-
plemented medium. In the richest medium, cocoa extract (5mg/
ml) and epicatechin (200–400mM) enhanced significantly IL-4
release by about 3- and 4·5-fold, respectively (P,0·05; Fig. 4).
Surprisingly, this effect was not observed when the medium
was supplemented with 1 % FCS (data not shown). Similarly,
when flavonoids were added 2 h before PMA activation, there
was no effect on IL-4 production by EL4.BU.OU6 cells (data
not shown).
Fig. 2. Effects of epicatechin and cocoa extract on IL-2 receptor a (CD25) expression of activated EL4.BU.OU6 cells when added simultaneously to phorbol 12-
myristate 13-acetate (PMA) in conditions of 10% fetal calf serum (FCS; (A)) and 1% FCS (B); and (C), when added 2 h previously in conditions of 1% FCS. Each
bar in (A) and (B) represents the mean of ten values with their standard error of the mean obtained from three separate experiments. In (C) each bar represents
the mean of six values with their standard error of the mean obtained from three individual experiments. Significant differences between control (PMA þ IL-1-
stimulated cells, B) and stimulated cells treated with epicatechin (r) or cocoa extract (A) are marked by *P,0·05 and **P,0·01. Significant differences between
stimulated cells treated with 200 and 400mM-epicatechin and stimulated cells treated with cocoa extract are marked by †P,0·01 and ‡P,0·01, respectively.
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Discussion
In this study, the down-modulating effects of cocoa flavonoids on
T lymphocyte activation have been established. T cell activation
occurs in the specific immune response when an antigen is pre-
sented by specialised cells, in the context of the main histocom-
patibility complex class II molecules, to specific, naive T helper
(Th) lymphocytes. After the specific recognition of antigenic pep-
tides by T cell receptors, an intracellular signals cascade is trig-
gered that involves the production of IL-2 (Powell et al. 1998).
IL-2 binds to and signals through a receptor complex consisting
of three subunits designated IL-2Ra (CD25), IL-2Rb (CD122)
and IL-2Rg (CD132) (Nelson & Willerford, 1998). All three sub-
units are required for high-affinity binding of IL-2. IL-2 by inter-
acting with its specific cell receptor leads to the stimulation of a
set of complex signal transduction pathways resulting in cell pro-
liferation (Greene & Leonard, 1986; Hatakeyama & Taniguchi,
1990). In addition to its potent T cell growth-stimulatory activity,
IL-2 mediates multiple biological processes, including growth and
differentiation of B cells (Waldmann et al. 1984). Activated Th
lymphocytes can be divided into two distinct subsets of effector
cells based on the profile of cytokines that they produce (Constant
& Bottomly, 1997). The Th1 subset secretes cytokines usually
associated with inflammation, such as IFN-g and TNF-a and
induces cell-mediated immune responses. The Th2 subset
Fig. 3. Effects of epicatechin and cocoa extract on IL-2 secretion of activated EL4.BU.OU6 cells when added simultaneously to phorbol 12-myristate 13-acetate
(PMA) in conditions of 10% fetal calf serum (FCS; (A)) and 1% FCS (B); and (C), when added 2 h previously in conditions of 1% FCS. Each bar in (A) and (B)
represents the mean of ten values with their standard error of the mean obtained from three separate experiments. In (C) each bar represents the mean of six
values with their standard error of the mean obtained from three individual experiments. Significant differences between control (PMA þ IL-1-stimulated cells, B)
and stimulated cells treated with epicatechin (r) or cocoa extract (A) are marked by *P,0·05 and **P,0·01. Significant differences between stimulated cells trea-
ted with 200 and 400mM-epicatechin and stimulated cells treated with cocoa extract are marked by †P,0·01 and ‡P,0·01, respectively.
Fig. 4. Effect of epicatechin and cocoa extract on IL-4 secretion of activated
EL4.BU.OU6 cells in conditions of 10% fetal calf serum-supplemented media
(*P,0·05). Each bar represents the mean of ten values with their standard
error of the mean obtained from three separate experiments. Significant
differences between control (phorbol 12-myristate 13-acetate þ IL-1-stimu-
lated cells, B) and stimulated cells treated with epicatechin (r) or cocoa
extract (A) are marked by *P,0·05.
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produces cytokines such as IL-4 and IL-5 that help B cells to pro-
liferate and differentiate and is associated with humoral immune
responses. Th2 cells also produce IL-10 which suppresses Th1
cells (Constant & Bottomly, 1997). IL-4 is mainly produced by
activated Th2 cells and plays an important role in regulating
Th1/Th2 balance. It has been found that IL-4 down-regulates
Th1 function involved in autoimmune diseases such as psoriasis
and arthritis (Allen et al. 1993; Ghoreschi et al. 2003).
This study was performed in the lymphoid cell line
EL4.BOU.OU6 from murine thymoma that can be activated by
PMA and IL-1 (Stoeck et al. 1989). PMA is a potent protein
kinase C activator which causes dose-dependent IL-2 secretion
and surface IL-2Ra expression in EL4.BU.OU6 cells. The com-
bined addition of IL-1a with PMA in these cells results in a
synergistic increase in IL-4 production. Therefore, PMA addition
in EL4.BU.OU6 induces cell activation through a similar pathway
to antigen binding to T cell receptors (Dornand et al. 1992). This
model allowed us to study the effect of an extract from
Theobroma cacao and the effect of epicatechin alone, in the
initial phases of the specific immune activation. Epicatechin
was chosen since it is the main flavonoid in cocoa; however,
the purified cocoa polyphenolic extract contains a wider flavonoid
spectrum (monomers and oligomers; Hammerstone et al. 1999)
which may explain the differences obtained in some results.
Cocoa extract was able to decrease the surface IL-2Ra (CD25)
expression induced by PMA and to diminish IL-2 secretion on the
lymphoid line EL4.BU.OU6. We are not aware of any previous
studies about cocoa extract and epicatechin on the a chain of
the IL-2 receptor (CD25). The decrease of the expression of
this receptor could be related to minor production of IL-2, but
there are discordant results about this. Thus, some authors have
found that IL-2Ra (CD25) expression is induced by IL-2
(Depper et al. 1985; Smith & Cantrell, 1985), whereas others
fail to observe such a relation (Proust et al. 1991; Alileche et al.
2001). In any case, treatment of the lymphoid cell line with cocoa
extract decreases IL-2Ra (CD25) expression on the lymphocyte
surface which results in a cell less sensitive to the autocrine
effect of IL-2. The ability of cocoa extract to decrease IL-2Ra
(CD25) expression was higher than that of epicatechin alone
in some conditions. This fact may be due to the composition of
cocoa extract: 40 % epicatechin, catechin and dimer procyanidins,
and 60 % trimer-decamer procyanidins (Rios et al. 2003).
These procyanidins seem to be more active on lymphocytes
than epicatechin alone.
Our results about cocoa flavonoids on IL-2 secretion agree with
those of Sanbongi et al. (1997) who found that cocoa liquor poly-
phenols inhibited both IL-2 mRNA expression and IL-2 secretion
by T cells from human peripheral blood. Moreover, we agree with
the results of Mao et al. (1999, 2000c) that show that crude cocoa
extract and pentamer, hexamer and heptamer procyanidin frac-
tions from cocoa extract reduced IL-2 transcription in human peri-
pheral blood lymphocytes. In this sense, our results also show that
cocoa extract decreases IL-2 secretion more effectively
than epicatechin alone, either demonstrating a greater action of
procyanidins or the synergistic effect between cocoa flavonoids.
Other flavonoids produce similar effects on T cell function.
Thus, genistein inhibited T cell proliferation, IL-2 synthesis and
IL-2Ra (CD25) expression without toxic effects on T cells
(Atluru et al. 1991). Moreover, low doses of rooibos tea extract
have been found to reduce IL-2 secretion from primed murine
splenocytes (Kunishiro et al. 2001). Furthermore, pycnogenol
reduces IL-2 production in stimulated Jurkat E6·1 cells (Cho
et al. 2001), and kaempferol is able to reduce IFN-g and IL-2 pro-
duction by T cells (Okamoto et al. 2002). Recently, prenylated
flavones from Artocarpus elasticus have shown a potent inhibition
of IL-2 secretion from stimulated splenocytes (Cerqueira et al.
2003) and there exists an in vivo study showing that low doses
of silymarin have an inhibitory effect on T-lymphocyte function
(Johnson et al. 2003). Cocoa extract, like other flavonoids, modu-
lates IL-2 secretion in activated lymphocytes. This effect, together
with a minor IL-2Ra (CD25) expression, may down-regulate the
early activation phase of lymphocyte and, therefore, the sub-
sequent activation of effector lymphoid cells. This could be
useful in some states of the exacerbated immune response, as in
hypersensitivity and autoimmune diseases.
The effects of epicatechin and cocoa extract on IL-2Ra (CD25)
expression and IL-2 secretion were more patent in 1 % FCS than
in 10 % FCS medium. In the former condition, cells secreted less
IL-2 (about half) than in the latter. This difference in cytokine
secretion in 1 % FCS medium may be due to stress from lack
of nutrition. Since cells were less responsive to PMA in 1 %
FCS medium, it must be easier to modulate them than in 10 %
FCS conditions. On the other hand, flavonoids produce a higher
inhibitory effect when they are added 2 h before stimulation
than when added simultaneously. These 2 h before stimulation
may be necessary to enhance the entry of flavonoids into the
cell and modulate gene expression. Alternatively, this time
period could be necessary to hydrolyse procyanidins from cocoa
extract in smaller fractions able to enter into the cell.
The intracellular mechanisms responsible for the effect of
cocoa and epicatechin on lymphocyte activation still need to be
elucidated. There has been a recent description of the effect of
epicatechin and dimeric procyanidins on PMA-activated Jurkat
cells, a lymphoid cell line (Mackenzie et al. 2004). This study
shows that flavonoids, by means of their antioxidant activity or
other actions, decrease NF-kB activation. The inhibition of NF-
kB might also mediate the down-regulation of IL-2 and IL-2Ra
(CD25) expression in our cells. Moreover, a polyphenolic cocoa
extract on Caco-2 cell line produces partial overexpression and
underexpression of several genes, some of which are involved
in the cellular response to oxidative stress whilst others are
involved in the expression of cell surface receptors and cell
signalling (Noe´ et al. 2004). These data suggest intricate mechan-
isms of action of cocoa flavonoids at the molecular level.
In the present study, a clear enhancement of IL-4 secretion was
found after epicatechin addition and a tendency to increase IL-4
secretion was observed after cocoa treatment. In this sense,
Mao et al. (1999) also found that monomer cocoa flavonoids
enhanced the levels of secretory IL-4 in phytohemagglutinin-
stimulated blood mononuclear cells. Moreover, these authors
reported that hexamer-octamer procyanidins presented an inhibi-
tory effect on this cytokine and the remaining procyanidins
showed no statistically significant effects. These results may
explain the higher effect of epicatechin in comparison with
cocoa extract observed in the present study. In any case, these
results may suggest that cocoa flavonoids could favour Th2 lym-
phocyte activation. To some degree, when the immune response is
askew to Th2 activation, Th1 activity and the inflammatory
response are down-regulated reciprocally. The opposite effect of
cocoa on IL-2 and IL-4 secretions suggests the action of flavo-
noids through different pathways involved in cytokine production
and secretion by lymphocytes.
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In summary, we find that T lymphocyte activation and there-
fore the specific immune response are down-modulated by
cocoa extract and epicatechin. This fact could be important in
some states of the immune system hyperactivity such as auto-
immune or chronic inflammatory diseases.
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